RESEARCH PROJECTS

At defeatHIV, our top priority is to achieve results, and we know that our success depends on the quality of our collaborations and partnerships. Our approach is to build strategic networks between scientists and community, or between academia, industry and the clinic that will help advance our work towards an HIV cure accessible to everyone who needs it. Learn more about the science we’re passionate about and get in touch with us to see how you can get involved.

 HIV-RESISTANT ANTI-HIV

CAR T CELLS

IRF1 Leaders & Industry Partners:

  • Lawrence Corey, MD, Fred Hutchinson Cancer Research Center • Seattle, Washington

  • David Rawlings, MD, Seattle Children’s Hospital • Seattle, Washington

  • Thor Wagner, MD, Seattle Children’s Hospital • Seattle, Washington

  • Juno Therapeutics, Seattle, Washington

  • Gilead Sciences, Foster City, California

  • Sangamo BioSciences, Richmond, California

ECD4-IG BASED THERAPY FOR HIV CURE

IRF2 Leaders & Industry Partners:

  • Michael Farzan, PhD, The Scripps Research Institute Florida • Jupiter, Florida

  • Emmune, Inc., Jupiter, Florida

  • Gilead Sciences, Foster City, California

GENETIC PROTECTION OF
T CELLS AFTER
THERAPEUTIC VACCINATION

IRF3 Leaders & Industry Partners:

  • James Mullins, PhD, University of Washington • Seattle, Washington

  • Deborah Fuller, PhD, University of Washington • Seattle, Washington

  • Hans-Peter Kiem, MD, PhD, Fred Hutchinson Cancer Research Center • Seattle, Washington

  • Sangamo BioSciences, Richmond, California

  • Gilead Sciences, Foster City, California

 
  • Facebook
  • Twitter
  • YouTube

©2021 by defeatHIV